The Green Chemistry Group, a non-profit organization dedicated to promoting the benefits of environmentally-friendly research and development processes, will host the 1st International Conference on Supercritical Fluid Chromatography (SFC) September 23-25, 2007 at the Sheraton Station Square Hotel in Pittsburgh, Pennsylvania.
The Green Chemistry Group, a non-profitorganization dedicated to promoting the benefits of environmentally-friendly research anddevelopment processes, will host the 1st International Conference onSupercritical Fluid Chromatography (SFC) September 23-25, 2007 at the Sheraton Station Square Hotel inPittsburgh, Pennsylvania. Distinguished chemists and academicians from Singapore,Malaysia, Germany, Switzerland, Norway, and Nigeria and their US counterparts will introduce and discuss new developments, applications and economics of SFC methodsdevelopment.
SFC is a burgeoning technology used primarily in the pharmaceutical industry. It harnesses the power of one of nature?s most commonelements, CO2, in the drug discovery process.
Dr. John Warner, president and chief technology officer of the Warner-BabcockInstitute for Green Chemistry, will deliver the keynote address on Monday, September 24at 8:00 am. The Scientific Program is comprised of speakers from major pharmaceuticalcompanies such as Proctor & Gamble, Merck, Pfizer, GlaxoSmithKline, AstraZeneca andBristol-Myers Squibb. The conference will also feature exhibits, workshops, and postersessions.
Visit the website www.greenchemistrygroup.org and click on Scientific Program for theschedule of events. The Green Chemistry Group welcomes your attendance. Pleaseemail info@greenchemistrygroup.org with questions or interest in attending theconference.
Pharmaceutical excipients, such as polyethylene glycol-based polymers, must be tested for the presence of ethylene oxide (EtO) and 1,4-dioxane as part of a safety assessment, according to USP Chapter <228>.
AOAC International Awarded NIST Grant for Developing Drug Testing Standards
October 31st 2024The grant will be part of a new collaborative scientific initiative to address the need for standards that define the desired performance of lateral flow immunoassay test strips to detect illicit drugs in tablets and powders.